Blocking TRAIL-DR5 signaling with soluble DR5 reduces delayed neuronal damage after transient global cerebral ischemia.

Source:http://linkedlifedata.com/resource/pubmed/id/20359534

Download in:

View as

General Info

PMID
20359534